Search Results - "Camp, Heidi S." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)

by Parmentier, Julie M, Voss, Jeff, Graff, Candace, Schwartz, Annette, Argiriadi, Maria, Friedman, Michael, Camp, Heidi S, Padley, Robert J, George, Jonathan S, Hyland, Deborah, Rosebraugh, Matthew, Wishart, Neil, Olson, Lisa, Long, Andrew J
Published in BMC rheumatology (01.01.2018)

Get full text

Journal Article

Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

by Strand, Vibeke, Pope, Janet, Tundia, Namita, Friedman, Alan, Camp, Heidi S, Pangan, Aileen, Ganguli, Arijit, Fuldeore, Mahesh, Goldschmidt, Debbie, Schiff, Michael
Published in Arthritis research & therapy (09.12.2019)

Get full text

Journal Article

Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY

Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY

by Strand, Vibeke, Tundia, Namita, Wells, Alvin, Buch, Maya H, Radominski, Sebastiao C, Camp, Heidi S, Friedman, Alan, Suboticki, Jessica L, Dunlap, Kendall, Goldschmidt, Debbie, Bergman, Martin
Published in Rheumatology (Oxford, England) (01.07.2021)

Get full text

Journal Article

Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial

Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial

by van Vollenhoven, Ronald, Strand, Vibeke, Takeuchi, Tsutomu, Chávez, Nilmo, Walter, Pablo Mannucci, Singhal, Atul, Swierkot, Jerzy, Khan, Nasser, Bu, Xianwei, Li, Yihan, Penn, Sara K, Camp, Heidi S, Aelion, Jacob
Published in Arthritis research & therapy (29.07.2024)

Get full text

Journal Article

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis

by Ezzedine, Khaled, Soliman, Ahmed M., Li, Chao, Camp, Heidi S., Pandya, Amit G.
Published in Dermatology and therapy (01.10.2023)

Get full text

Journal Article

Disease Course, Treatment Patterns and Goals Among Patients with Non-segmental Vitiligo Across Europe and the United States

Disease Course, Treatment Patterns and Goals Among Patients with Non-segmental Vitiligo Across Europe and the United States

by Rosmarin, David, Soliman, Ahmed M., Marwaha, Simran, Piercy, James, Camp, Heidi S., Anderson, Peter, Ezzedine, Khaled
Published in Dermatology and therapy (01.07.2024)

Get full text

Journal Article

Health-Related Quality of Life Burden Among Adults with Vitiligo: Relationship to Disease Severity and Disease Location

Health-Related Quality of Life Burden Among Adults with Vitiligo: Relationship to Disease Severity and Disease Location

by Rosmarin, David, Soliman, Ahmed M., Piercy, James, Marwaha, Simran, Anderson, Peter, Camp, Heidi S.
Published in Dermatology and therapy (01.06.2024)

Get full text

Journal Article

Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

by Strand, Vibeke, Pope, Janet, Tundia, Namita, Friedman, Alan, Camp, Heidi S, Pangan, Aileen, Ganguli, Arijit, Fuldeore, Mahesh, Goldschmidt, Debbie, Schiff, Michael
Published in Arthritis research & therapy (09.06.2020)

Get full text

Journal Article

Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study

Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study

by Fleischmann, Roy, Meerwein, Sebastian, Charles-Schoeman, Christina, Combe, Bernard, Hall, Stephen, Khan, Nasser, Carter, Kyle M, Camp, Heidi S, Rubbert-Roth, Andrea
Published in Rheumatic & musculoskeletal diseases open (25.07.2024)

Get full text

Journal Article

$Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study$

Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study

by Rubbert-Roth, Andrea, Kato, Koji, Haraoui, Boulos, Rischmueller, Maureen, Liu, Yanxi, Khan, Nasser, Camp, Heidi S., Xavier, Ricardo M.
Published in Rheumatology and therapy. (01.10.2024)

Get full text

Journal Article

Simultaneous quantification of malonyl-CoA and several other short-chain acyl-CoAs in animal tissues by ion-pairing reversed-phase HPLC/MS

Simultaneous quantification of malonyl-CoA and several other short-chain acyl-CoAs in animal tissues by ion-pairing reversed-phase HPLC/MS

by Gao, Lan, Chiou, William, Tang, Hua, Cheng, Xueheng, Camp, Heidi S., Burns, David J.
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (15.06.2007)

Get full text

Journal Article

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

by Smolen, Josef S, Pangan, Aileen L, Emery, Paul, Rigby, William, Tanaka, Yoshiya, Vargas, Juan Ignacio, Zhang, Ying, Damjanov, Nemanja, Friedman, Alan, Othman, Ahmed A, Camp, Heidi S, Cohen, Stanley
Published in The Lancet (British edition) (08.06.2019)

Get full text

Journal Article

Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors

Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors

by Liu, Gang, Lynch, John K, Freeman, Jennifer, Liu, Bo, Xin, Zhili, Zhao, Hongyu, Serby, Michael D, Kym, Philip R, Suhar, Tom S, Smith, Harriet T, Cao, Ning, Yang, Ruojing, Janis, Rich S, Krauser, Joel A, Cepa, Steven P, Beno, David W. A, Sham, Hing L, Collins, Christine A, Surowy, Teresa K, Camp, Heidi S
Published in Journal of medicinal chemistry (28.06.2007)

Get full text

Journal Article

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial

by Burmester, Gerd R, Kremer, Joel M, Van den Bosch, Filip, Kivitz, Alan, Bessette, Louis, Li, Yihan, Zhou, Yijie, Othman, Ahmed A, Pangan, Aileen L, Camp, Heidi S
Published in The Lancet (British edition) (23.06.2018)

Get full text

Journal Article

c-Jun N-Terminal Kinase Phosphorylates Peroxisome Proliferator-Activated Receptor-γ1 and Negatively Regulates Its Transcriptional Activity

c-Jun N-Terminal Kinase Phosphorylates Peroxisome Proliferator-Activated Receptor-γ1 and Negatively Regulates Its Transcriptional Activity

by Camp, Heidi S, Tafuri, Sherrie R, Leff, Todd
Published in Endocrinology (Philadelphia) (01.01.1999)

Get full text

Journal Article

A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy

A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy

by Kremer, Joel M., Emery, Paul, Camp, Heidi S., Friedman, Alan, Wang, Li, Othman, Ahmed A., Khan, Nasser, Pangan, Aileen L., Jungerwirth, Steven, Keystone, Edward C.
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2016)

Get full text

Journal Article

Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors

Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors

by Xin, Zhili, Zhao, Hongyu, Serby, Michael D., Liu, Bo, Liu, Mei, Szczepankiewicz, Bruce G., Nelson, Lissa T.J., Smith, Harriet T., Suhar, Tom S., Janis, Rich S., Cao, Ning, Camp, Heidi S., Collins, Christine A., Sham, Hing L., Surowy, Teresa K., Liu, Gang
Published in Bioorganic & medicinal chemistry (01.08.2008)

Get full text

Journal Article

Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

by Genovese, Mark C., Smolen, Josef S., Weinblatt, Michael E., Burmester, Gerd R., Meerwein, Sebastian, Camp, Heidi S., Wang, Li, Othman, Ahmed A., Khan, Nasser, Pangan, Aileen L., Jungerwirth, Steven
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2016)

Get full text

Journal Article

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials

by Winthrop, Kevin L, Nash, Peter, Yamaoka, Kunihiro, Mysler, Eduardo, Khan, Nasser, Camp, Heidi S, Song, Yanna, Suboticki, Jessica L, Curtis, Jeffrey R
Published in Annals of the rheumatic diseases (01.02.2022)

Get full text

Journal Article

Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis

Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis

by Mohamed, Mohamed-Eslam F., Camp, Heidi S., Jiang, Ping, Padley, Robert J., Asatryan, Armen, Othman, Ahmed A.
Published in Clinical pharmacokinetics (01.12.2016)

Get full text

Journal Article

1
2
3
4
5
6
Next
[6]